Welcome to Stanton Glantz blog
Commentary on tobacco, cannabis and public health
Latest from the Blog
FDA should not authorize marketing flavored ZYN a modified risk claim because they will harm youth
My colleagues at UCSF and Stanford have submitted this public comment to FDA opposing its approval of Swedish Match (owned by Philip Morris International) claim that ZYN is less dangerous because of particular adverse effects on youth (PDF). The TPSAC tracking number is mk4-kp68-wmg2 and the general docket tracking number is mk5-q1p5-yauh on Regulations.gov. FDA…
The gateway has two doors in England, too
With some notable exceptions. e-cigarettes have been embraced by British tobacco control advocates and public health authorities more enthusiastically than anywhere else in the world, including authorities at Action on Smoking and Health (ASH) and University College London (UCL). Now, Emily Banks, Andrew Bush, Charlotta Pisinger, and Sam Egger have published Signs of increased smoking…
FDA should not authorize marketing ZYN nicotine pouches as having lower risk because the claim is likely to be misinterpreted to mean ZYN has been approved by FDA for cessation and consumers do not understand that they need to switch completely to get the purported benefits
My colleagues at UCSF and Stanford have submitted this public comment to FDA opposing its approval of Swedish Match (owned by Philip Morris International) claim that ZYN is less dangerous because it will be misunderstood as saying FDA endorsed ZYN (PDF). The TPSAC tracking number is mk4-kxvh-7j9n and the general docket tracking number is mk5-q1p5-yauh…
Get new content delivered directly to your inbox.
Stanton Glantz blog 